Graves' disease with moderate-severe endocrine ophthalmopathy-long term results of a prospective, randomized study of total or subtotal thyroid resection

Thyroid

Volumn 15, Issue 10, 2005, Pages 1157-1164

  Järhult, Johannes ^a,e   Rudberg, C ^b   Larsson, E ^c   Selvander, H ^a   Sjovall K ^d   Winsa, B ^c   Rastad, J ^c   Karlsson, F A ^c  

^a Eksjo Hospital   (Sweden)

^b Vasteras Hospital   (Sweden)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^d Västmanland Hospital Vasteras   (Sweden)

^e RYHOV COUNTY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; CORTICOSTEROID; LIOTHYRONINE; THYROTROPIN RECEPTOR ANTIBODY; THYROXINE;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; CHEMOSIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOCRINE OPHTHALMOPATHY; EXOPHTHALMOS; EYELID EDEMA; FEMALE; FOLLOW UP; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; GRAVES DISEASE; HUMAN; HYPOPARATHYROIDISM; LENGTH OF STAY; MALE; OPERATION DURATION; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT LARYNGEAL NERVE PALSY; REOPERATION; SCORING SYSTEM; SUBTOTAL THYROIDECTOMY; THYROID WEIGHT; THYROIDECTOMY; VISUAL ANALOG SCALE; VOCAL CORD PARALYSIS;

ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; GRAVES OPHTHALMOPATHY; HUMANS; MALE; MIDDLE AGED; OCULAR MOTILITY DISORDERS; RECEPTORS, THYROTROPIN; THYROIDECTOMY;

EID: 28344432432     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2005.15.1157     Document Type: Article

References (31)

1. Winsa B, Rastad J, Åkerstöm G, Johansson H, Westermark K, Karlsson A 1995 Retrospective evaluation of subtotal and total thyroidectomy in Graves' disease with and without endocrine ophthalmopathy. Eur J Endocrinol 132:406-412.
2. Catz B, Perzik SL 1969 Total thyroidectomy in the management of thyrotoxic and euthyroid Graves' disease. Am J Surg 118:435-439.
3. Bergamini C, Borelli A, Reddavide S, Borelli D 2000 The results of total thyroidectomy in Basedow's disease. The authors' personal experience of 180 cases. G Chir 21:160-166.
4. Witte J, Goretzki PE, Dotzenrath C, Simon D, Felis P, Neubauer M, Roher HD 2000 Surgery for Graves' disease: Total versus subtotal thyroidectomy-Results of a prospective randomized trial. Word J Surg 24:1303-1311.
5. Karlsson FA, Dahlberg PA, Jansson R, Westermark K, Enoksson P 1989 Importance of TSH receptor activation in the development of severe endocrine ophthalmopathy. Acta Endocrinol (Copenh) 121 (Suppl 2):132-141.
6. Weetman AP, Wiersinga WM 1998 Current management of thyroid-associated ophthalmopathy in Europe. Results of an international survey. Clin Endocrinol 49:21-28.
7. Tallstedt L, Lundell G, Tørring O, Wallin G, Ljunggren JG, Blomgren H, Taube A, the Thyroid Study Group 1992 Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism. N Engl J Med 326:1733-1738.
8. Abe Y, Sato H, Noguchi M, Mimura T, Sugino K, Ozaki O, Yoshimura H, Ito K 1998 Effect of subtotal thyroidectomy on natural history of ophthalmopathy in Graves' disease. World J Surg 22:714-717.
9. Franklyn JA, Daykin J, Drolc M, Farmer M, Sheppard MC 1991 Long-term follow-up of treatment of thyrotoxicosis by three different methods. Clin Endocrinol (Oxf) 34:71-76.
10. Böttger T 1997 Morbus Basedow: Thyreoidektomie oder subtotale Resektion? Zentralbl Chir 122:231-235.
11. Möbius E, Niermann B, Zielke A, Rothmund M 1998 Post-operative Komplikationen und Langzeitergebnisse der chirurgischen Therapie der Immunthyreopathie vom Typ Basedow. Dtsch Med Wochenschr 123:1297-1302.
12. Bartalena L, Marcocci C, Bogazzi F, Manetti L, Tanda ML, Dell'Unto E, Bruno-Bossio G, Nardi M, Bartolomei MP, Lepri A, Rossi G, Martine E, Pinchera A 1998 Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy. N Engl J Med 338:73-78.
13. Grussendorf M, Horster FA, Inane Y, Goretzki PE, Roher HD, Kmskemper HL 1988 Subtotal thyroidectomy as a superior therapeutic principle in treatment of endocrine ophthalmopathy: A comparison with retrobulbar irradiation and thyrostatic therapy alone. Wien Klin Wochenschr 100:355-357.
14. Frilling A, Goretzki PE, Grussendorf M, Erbslöh M, Roher HD 1990 The influence of surgery on endocrine ophthalmopathy. World J Surg 14:442-46.
15. Agarwal A, Mishra SK 2001 Role of surgery in the management of Graves' disease. J Indian Med Assoc 99:254-256.
16. Miccoli P, Vitti P, Rago T, Iacconi P, Bartalena L, Bogazzi F, Fiore E, Valeriano R, Chiovato L, Rocchi R, Pinchera A 1996 Surgical treatment of Graves' disease: Subtotal or total thyroidectomy? Surgery 120:1020-1025.
17. Levitt MD, Edis AJ, Agnello R, McCormick CC 1988 The effect of subtotal thyroidectomy on Graves' ophthalmopathy. World J Surg 12:593-597.
18. Marcocci C, Bruno-Bosslo G, Manetti L, Tanda ML, Miccoli M, Iacconi P, Bartolomel MP, Nardi M, Pinchera A, Bartalena L 1999 The course of Graves' ophthalmopathy is not influenced by near total thyroidectomy: A case-control study. Clin Endocrinol 51:503-508.
19. Werner SC, Feind CR, Aida M 1967 Graves' disease and total thyroidectomy. N Engl J Med 276:132-137.
20. Dralle H, Sekulla C 2004 Morbidity after subtotal and total thyroidectomy in patients with Graves' disease: The basis for decision-making regarding surgical indication and extent of resection. Z Arztl Fortbild Qualitatssich 98(Suppl 5):45-53.
21. Werga-Kjellman P, Zedenius J, Tallstedt L, Traisk F, Lundell G, Wallin G 2001 Surgical treatment of hyperthyroidism: A ten-year experience. Thyroid 11:187-192.
22. Takamura Y, Nakano K, Uruno T, Ito Y, Miya A, Kobayashi K, Yokozawa T, Matsuzuka F, Kuma K, Miyauchi A 2003 Changes in serum TSH receptor antibody (TRAb) values in patients with Graves' disease after total or subtotal thyroidectomy. Endocr J 50:595-601.
23. Sugino K, Mimura T, Ozaki O, Kure Y, Iwasaki H, Wada N, Matsumoto A, Ito K 1995 Early recurrence of hyperthyroidism in patients with Graves' disease treated by subtotal thyroidectomy. World J Surg 19:648-652.
24. Karlsson FA, Dahlberg PA 1981 Thyroid stimulating antibodies (TSAb) in patients with Graves' disease undergoing antithyroid drug treatment: Indicators of activity of disease. Clin Endocrinol 14:579-585.
25. Orgiazzi J 2000 Anti-TSH receptor antibodies in clinical practice. Endocrinol Metab Clin North Am 29:339-535.
26. Gamstedt A, Wadman B, Karlsson A 1991 Pretreatment with betamethasone of patients with Graves' disease given radioiodine therapy: Thyroid autoantibody responses and outcome of therapy. J Clin Endocrinol Metab 73:125-131.
27. Matsubayashi S, Tamai H, Takaichi Y, Morita T, Matsuzuka F, Suzuki T, Kuma K, Nagataki S 1988 Thyroidal prelymphoma. J Endocrinol Invest 11:211-214.
28. Chiovato L, Latrofa F, Braverman LE, Pacini F, Capezzone M, Masserini L, Grasso L, Pinchera A 2003 Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens. Ann Intern Med 139:346-351.
29. Zinkernagel RM 2002 On differences between immunity and immunological memory. Curr Opin Immunol 14:523-536.
30. Midhagen G, Aberg AK, Olcen P, Jarnerot G, Valdimarsson T, Dahlbom I, Hansson T, Strom M 2004 Antibody levels in adult patients with coeliac disease during gluten-free diet: A rapid initial decrease of clinical importance. J Intern Med 256:519-524.
31. Gerding MN, van der Meer JW, Broenink M, Bakker O, Wiersinga WM, Prummel MF 2000 Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy. Clin Endocrinol (Oxf) 52:267-271.